Mathew Thomas

3.6k citations
28 papers · 2.2k indexed · 1 hit paper · h-index 12
Topics
Systemic Lupus Erythematosus Research (6 papers)Monoclonal and Polyclonal Antibodies Research (5 papers)Chronic Lymphocytic Leukemia Research (4 papers)
Partner nations
United StatesIndiaBrazil

In The Last Decade

Mathew Thomas

26 papers receiving 2.1k citations

Hit Papers

Efficacy and safety of belimumab in patients with active ...201120262016202120114008001.2k

Peers

Mathew Thomas
Comparison fields: 5 of 86
  • Rheumatology 1.5k
  • Immunology 1.3k
  • Radiology, Nuclear Medicine and Imaging 850
  • Pathology and Forensic Medicine 188
  • Epidemiology 188
Replace Sandra Navarra with:
Sandra Navarra Philippines
S. Lobatto Netherlands
Yelda Bilginer Türkiye
Nesrin Beşbaş Türkiye
D. Adu United Kingdom
Shigeko Inokuma Japan
Stephen P. McAdoo United Kingdom
Meliha C Kapetanovic Sweden
Fatoş Yalçınkaya Türkiye
Emmanuel de Maistre France
Mathew Thomas relative to Sandra Navarra Philippines Sandra Navarra's profile →
Citations per field
00.5×1.5×
Sandra Navarra · 1×
Citations per year

Countries citing papers authored by Mathew Thomas

Since Specialization
Citations

This map shows the geographic impact of Mathew Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathew Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathew Thomas more than expected).

Fields of papers citing papers by Mathew Thomas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mathew Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathew Thomas. The network helps show where Mathew Thomas may publish in the future.

Co-authorship network of co-authors of Mathew Thomas

This figure shows the co-authorship network connecting the top 25 collaborators of Mathew Thomas. A scholar is included among the top collaborators of Mathew Thomas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mathew Thomas. Mathew Thomas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 5
2 46
3 11
4 3
5 5
6 11
7 14
8 4
9 311
10 10
11 88
12
Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trialbreakdown →
1401
13 2
14 4
15 1
16 5
17 66
18 9
19 0
20 41

About Mathew Thomas

Mathew Thomas is a scholar working on Applied Microbiology and Biotechnology, Genetics and Rheumatology, having authored 28 papers that have together received 2.2k indexed citations. Recurring topics across this work include Systemic Lupus Erythematosus Research (6 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). The work is most often cited by research in Rheumatology (1.5k citations), Immunology (1.3k citations) and Radiology, Nuclear Medicine and Imaging (850 citations). Mathew Thomas has collaborated with scholars based in United States, India and Brazil. Frequent co-authors include Z. John Zhong, William W. Freimuth, Lilia Pineda, A Gallacher, Roger A. Levy, Sandra Navarra, Stephen Hall, C Tănăsescu, Michelle Petri and Joung-Liang Lan. Their work appears in journals such as The Lancet, Blood and Annals of the Rheumatic Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026